Oppenheimer & Co’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.52M Sell
57,828
-19,513
-25% -$3.38M 0.12% 186
2025
Q4
$13.7M Buy
77,341
+12,070
+18% +$2.01M 0.2% 106
2025
Q3
$10.4M Sell
65,271
-26,616
-29% -$3.93M 0.13% 170
2025
Q2
$12.9M Buy
91,887
+8,494
+10% +$1.04M 0.17% 126
2025
Q1
$9.73M Sell
83,393
-36,150
-30% -$4.66M 0.15% 153
2024
Q4
$15M Sell
119,543
-4,010
-3% -$494K 0.22% 85
2024
Q3
$12.9M Sell
123,553
-9,291
-7% -$936K 0.2% 99
2024
Q2
$12.9M Buy
132,844
+2,064
+2% +$196K 0.2% 100
2024
Q1
$12.3M Sell
130,780
-17,663
-12% -$1.56M 0.2% 105
2023
Q4
$13.8M Buy
148,443
+6,379
+4% +$510K 0.25% 81
2023
Q3
$11.6M Sell
142,064
-28,799
-17% -$2.5M 0.24% 84
2023
Q2
$14.6M Buy
170,863
+6,494
+4% +$555K 0.29% 72
2023
Q1
$14.4M Buy
164,369
+24,156
+17% +$2.25M 0.31% 66
2022
Q4
$11.9M Sell
140,213
-1,472
-1% -$125K 0.27% 74
2022
Q3
$11.2M Buy
141,685
+3,256
+2% +$274K 0.26% 77
2022
Q2
$10.5M Buy
138,429
+38,454
+38% +$3.15M 0.23% 92
2022
Q1
$8.74M Buy
99,975
+31,131
+45% +$3M 0.16% 137
2021
Q4
$6.76M Buy
68,844
+5,671
+9% +$565K 0.12% 198
2021
Q3
$6.15M Sell
63,173
-4,475
-7% -$443K 0.12% 202
2021
Q2
$6.2M Sell
67,648
-1,219
-2% -$105K 0.11% 216
2021
Q1
$5.35M Sell
68,867
-10,796
-14% -$827K 0.11% 228
2020
Q4
$5.46M Buy
79,663
+3,181
+4% +$183K 0.12% 201
2020
Q3
$3.7M Sell
76,482
-576
-0.7% -$29K 0.09% 250
2020
Q2
$3.72M Sell
77,058
-10,210
-12% -$429K 0.1% 239
2020
Q1
$2.97M Buy
87,268
+12,878
+17% +$607K 0.09% 247
2019
Q4
$3.8M Buy
74,390
+3,259
+5% +$154K 0.09% 246
2019
Q3
$3.04M Buy
71,131
+7,604
+12% +$325K 0.08% 276
2019
Q2
$2.78M Buy
63,527
+1,470
+2% +$65.6K 0.08% 305
2019
Q1
$2.62M Buy
62,057
+22,718
+58% +$956K 0.07% 332
2018
Q4
$1.56M Sell
39,339
-4,904
-11% -$214K 0.05% 396
2018
Q3
$2.06M Sell
44,243
-11,317
-20% -$553K 0.05% 391
2018
Q2
$2.63M Sell
55,560
-22,385
-29% -$1.17M 0.07% 322
2018
Q1
$4.21M Sell
77,945
-27,597
-26% -$1.53M 0.11% 212
2017
Q4
$5.54M Buy
105,542
+30,363
+40% +$1.54M 0.14% 164
2017
Q3
$3.62M Buy
75,179
+2,864
+4% +$133K 0.1% 251
2017
Q2
$3.22M Sell
72,315
-13,642
-16% -$588K 0.09% 275
2017
Q1
$3.68M Buy
85,957
+16,041
+23% +$712K 0.1% 242
2016
Q4
$2.95M Sell
69,916
-28,283
-29% -$1.07M 0.09% 275
2016
Q3
$3.15M Sell
98,199
-2,958
-3% -$88.2K 0.09% 253
2016
Q2
$2.63M Sell
101,157
-11,882
-11% -$311K 0.08% 301
2016
Q1
$2.83M Sell
113,039
-29,842
-21% -$762K 0.09% 269
2015
Q4
$4.54M Sell
142,881
-63,680
-31% -$2.12M 0.14% 172
2015
Q3
$6.51M Buy
206,561
+7,066
+4% +$257K 0.2% 117
2015
Q2
$7.74M Buy
199,495
+8,114
+4% +$309K 0.22% 105
2015
Q1
$6.83M Buy
191,381
+36,086
+23% +$1.29M 0.19% 126
2014
Q4
$6.03M Buy
155,295
+32,257
+26% +$1.15M 0.17% 141
2014
Q3
$4.25M Sell
123,038
-11,155
-8% -$372K 0.13% 199
2014
Q2
$4.34M Sell
134,193
-12,031
-8% -$371K 0.13% 195
2014
Q1
$4.56M Buy
146,224
+32,528
+29% +$1M 0.14% 181
2013
Q4
$3.56M Sell
113,696
-21,109
-16% -$628K 0.11% 210
2013
Q3
$3.63M Buy
134,805
+21,112
+19% +$566K 0.13% 203
2013
Q2
$2.78M Buy
+113,693
New +$2.7M 0.11% 231

Other funds holding MS

Oppenheimer & Co's MS Position: Q1 2026 in Review

Oppenheimer & Co reduced its Morgan Stanley (MS) stake by 25% in Q1 2026, selling an estimated $3.38M and leaving 57,828 shares worth $9.52M. The position accounts for 0.12% of the portfolio, ranked #186.

Oppenheimer & Co first reported a position in MS in Q2 2013 and has held it in 52 quarters since. The position peaked at $15M in Q4 2024. 2,490 funds tracked by Wall St. Rank hold MS as of Q1 2026.

  • Oppenheimer & Co held 57,828 shares of Morgan Stanley worth $9.52M as of Q1 2026.
  • Oppenheimer & Co sold 19,513 Morgan Stanley shares in Q1 2026, an estimated $3.38M.
  • Morgan Stanley made up 0.12% of Oppenheimer & Co's portfolio in Q1 2026, its #186 holding.
  • Oppenheimer & Co first reported a position in Morgan Stanley in Q2 2013 and has held it in 52 quarters since.
  • Oppenheimer & Co's Morgan Stanley position peaked at $15M in Q4 2024.
  • 2,490 funds tracked by Wall St. Rank held Morgan Stanley as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.